Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1202
Recommendation HOLD
P/E 33.39
ROE 13.25 %
Capitalization 3,310,852,000 $
Dividend Yield 0.00 %
P/S 4.39
AII Position 465
P/E Position 447
ROE Position 309
Capitalization Position 647
Dividend Yield Position 629
Sales 753,800,000 $
10-Year Average Earnings 99,152,600 $
Shares Outstanding 72,400,000
Equity 748,100,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2016 6 753,800,000.00 $
2015 6 723,100,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2016 6 125,300,000.00 $
2015 6 80,200,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $
2008 6 47,845,000.00 $
2007 6 -34,962,000.00 $

Equity:

YEAR MONTH AMOUNT
2016 6 748,100,000.00 $
2015 6 662,100,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
620 87,737 MYRX MYREXIS INC 171,102 212,920 27,673 MYGN MYRIAD GENETICS 2,889,711 2,829,144 719,834 NABI NABI BIOPHARMA...
Aug 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Aug. 9
2.84 10.66 HPT HOSPITALITY PROP 0.89 0.81 9.9 0.86 3.5 2.45 12.86 MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 1.07 5.97 TNGN# TENGION INC...
Aug 9, 2011
U.S. Companies Reporting Earnings on Aug. 9
99.5 0.08 NM Jun MRVC# MRV COMM 0.01 na na 0.01 0.0 Jun MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 Jun TICKER ...
Aug 8, 2011
Implied Stock-Price Moves for U.S. Companies Reporting Results
53 7.22 08/09 Bef-mkt FOSL FOSSIL INC 1.02 8.44 8.30 08/09 Aft-mkt MYGN MYRIAD GENETICS 1.02 9.71 9.54 08/09 SPWRA SUNPOWER CORP-A ...
Jun 30, 2008
Movers: NDS Group, H&R Block, France Telecom, Mesa Air, Del Monte
5 million in second quarter and $5 million in the second half of 2008. Myriad Genetics (MYGN) reports of the Act-Earli-AD trial, an 18-month Phase 3 study of Flurizan in patients with mild...
May 22, 2001
Reaping the Bush Dividend
one called Human Genome Sciences (HGSI ), and there's another one called Myriad Genetics (MYGN ). I'm not necessarily recommending those firms as the best ones to look at, but I'm saying...
Nov 17, 2003
Raising Forecast for Children's Place
estimate: .55 Rationale: See stronger operating income Company: Myriad Genetics (MYGN ) Year ending: Jun-2004 Prior estimate: -1.11 New estimate: -1.34 ...
Dec 14, 2006
S&P Ups Oracle to Strong Buy
reflecting a multiple reduction due to the aforementioned sales risks. Myriad Genetics (MYGN): Cuts to 3 STARS (hold) from 4 STARS (buy) Analyst: Paul Starsia Our downgrade comes...
Jun 22, 2007
Stocks: Eleven Cash-Flow Champs
14.83 Myriad Genetics (MYGN) 36.64 ...
Dec 30, 2005
S&P's Top-Shelf Selections
of $135 billion for Procter & Gamble (PG ) to a low of $700 million for Myriad Genetics (MYGN ). By contrast, the median market capitalization of the S&P 500 index is about $10.3 billion...


Google News for MYRIAD GENETICS:

StreetInsider.com - 2 hours ago
Deutsche Bank Upgrades Myriad Genetics (MYGN) to Hold
Deutsche Bank upgraded Myriad Genetics (NASDAQ: MYGN) from Sell to Hold with a price target of $28.00 (from $20.00). Analyst Dan ...
Modern Readers
Myriad Genetics (MYGN) EndoPredict Secures Positive Coverage ...
Myriad Genetics, Inc. (NASDAQ: MYGN), the Medicare contractor who oversees the MolDx program and Anthem, Inc. (NYSE: ATNM) one of the ...
UtahHerald.com
Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes
On Aug 11, we issued an updated research report on Salt Lake City, UT-based molecular diagnostics provider, Myriad Genetics, Inc.MYGN .
StreetInsider.com - 16 hours ago
Myriad Genetics Announces Positive Coverage Decisions From ...
JPMorgan Checks In On Myriad Genetics Following 30% Rally · Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7%.
Nasdaq
Can Myriad Genetics (MYGN) Spring a Surprise in Q4 Earnings?
Myriad Genetics, Inc.MYGN is scheduled to report fourth-quarter fiscal 2017 results on Aug 8, after the closing bell. Last quarter, the company ...
CML News
Myriad Genetics' Stock Is Starting To Make A Run
One of those companies with potential is Myriad Genetics (MYGN). Myriad creates genetic tests to screen for genetic cancer risk and other ...
BBNS
Myriad Genetics (MYGN) Q4 2017 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Myriad Genetics Fourth Quarter 2017 Financial Earnings Conference Call.
Nasdaq - 3 days ago
Myriad Genetics (MYGN) Beats on Q4 Earnings & Revenues
Myriad Genetics, Inc. MYGN reported adjusted earnings per share (EPS) of 30 cents in the fourth quarter of fiscal 2017, down 17% year over ...
StockNewsJournal
Today's Analyst Moves: PRA Health Sciences, Inc. (PRAH), Myriad ...
Myriad Genetics, Inc. (NASDAQ:MYGN) is another stock that is grabbing investors attention these days. Its shares have trimmed -1.9% since ...
BNB Daily (blog)
Myriad Genetics' (MYGN) “Hold” Rating Reaffirmed at Cowen and ...
Myriad Genetics logo Myriad Genetics, Inc. (NASDAQ:MYGN)'s stock had its “hold” rating reaffirmed by research analysts at Cowen and ...


Back